SOURCE: DC Brands International, Inc.

November 14, 2007 12:05 ET

DC Brands New Sales Manager Sets Major Meeting

DENVER, CO--(Marketwire - November 14, 2007) - Yesterday DC Brands International (PINKSHEETS: DCBR) announced Jack Noble as a new addition to its sales team. The company is excited to report Noble has already set a meeting with a major east coast retailer for the week after Thanksgiving.

Jim Randall, DC Brands VP of Sales, said, "This is why I wanted to add Jack to our team -- he is a no nonsense guy that gets the job done. Jack has been in the industry for most of his life and has a stellar reputation. I look forward to many more great announcements with Jack on our team. Additionally, I know both the Sheya brothers are busy with appointments of their own, and I would think there will be some respectable news coming out before the year's end."

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBR), specializes in and manufactures unique energy drink brands. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with a beverage that filled the substantial NASCAR niche. With more than 75 million loyal fans, the NASCAR demographic presented an attractive opportunity to become one of the few racecar-themed energy drinks in the marketplace. Following much due diligence, research and testing, Turn Left Energy Drink recently came to fruition.

For more information on DC Brands International, visit their website at www.TurnLeftEnergy.com and DickensEnergyCider.com.

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information